Old Web
English
Sign In
Acemap
>
Paper
>
Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control
Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control
2018
Silvio E. Inzucchi
Mikhail Kosiborod
David Fitchett
Christoph Wanner
Uwe Hehnke
Stefan Kaspers
Jyothis T. George
Bernard Zinman
Keywords:
Glycemic
Cardiology
Type 2 Diabetes Mellitus
Diabetes mellitus
Medicine
Empagliflozin
Internal medicine
cardiovascular outcomes
treatment outcome
sodium glucose transporter 2
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
73
Citations
NaN
KQI
[]